Baldwin Wealth Partners LLC MA Has $10.10 Million Stock Position in Waters Co. (NYSE:WAT)

Baldwin Wealth Partners LLC MA cut its position in Waters Co. (NYSE:WAT) by 2.5% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 27,235 shares of the medical instruments supplier’s stock after selling 712 shares during the quarter. Baldwin Wealth Partners LLC MA’s holdings in Waters were worth $10,104,000 at the end of the most recent reporting period.

Other institutional investors have also recently bought and sold shares of the company. Kennebec Savings Bank bought a new stake in shares of Waters in the third quarter valued at approximately $33,000. Ashton Thomas Securities LLC acquired a new position in Waters during the 3rd quarter valued at $35,000. Fortitude Family Office LLC boosted its holdings in Waters by 235.7% in the 4th quarter. Fortitude Family Office LLC now owns 94 shares of the medical instruments supplier’s stock valued at $35,000 after purchasing an additional 66 shares during the period. Itau Unibanco Holding S.A. grew its position in Waters by 63.2% in the 3rd quarter. Itau Unibanco Holding S.A. now owns 186 shares of the medical instruments supplier’s stock worth $67,000 after purchasing an additional 72 shares during the last quarter. Finally, Eagle Bay Advisors LLC bought a new position in shares of Waters during the 4th quarter worth about $72,000. Institutional investors own 94.01% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts recently weighed in on WAT shares. Barclays increased their target price on shares of Waters from $330.00 to $360.00 and gave the company an “underweight” rating in a research note on Monday, November 4th. Stifel Nicolaus boosted their price objective on Waters from $332.00 to $360.00 and gave the company a “hold” rating in a research report on Monday, November 4th. Bank of America raised their target price on Waters from $400.00 to $430.00 and gave the stock a “neutral” rating in a research report on Friday, December 13th. Scotiabank initiated coverage on shares of Waters in a report on Monday, December 23rd. They issued a “sector perform” rating and a $430.00 price target on the stock. Finally, Deutsche Bank Aktiengesellschaft raised their price objective on shares of Waters from $310.00 to $325.00 and gave the stock a “hold” rating in a report on Monday, November 4th. One investment analyst has rated the stock with a sell rating, nine have given a hold rating, four have issued a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, Waters presently has a consensus rating of “Hold” and a consensus target price of $384.71.

Waters Price Performance

NYSE:WAT opened at $409.43 on Monday. The company has a quick ratio of 1.38, a current ratio of 2.02 and a debt-to-equity ratio of 1.14. The firm has a market cap of $24.31 billion, a PE ratio of 39.14, a price-to-earnings-growth ratio of 7.17 and a beta of 1.01. Waters Co. has a 12 month low of $279.24 and a 12 month high of $416.24. The company’s 50-day moving average price is $381.66 and its two-hundred day moving average price is $354.99.

Waters (NYSE:WAT) last announced its earnings results on Friday, November 1st. The medical instruments supplier reported $2.93 EPS for the quarter, topping the consensus estimate of $2.68 by $0.25. Waters had a return on equity of 49.93% and a net margin of 21.43%. The business had revenue of $740.30 million for the quarter, compared to the consensus estimate of $712.99 million. During the same period in the previous year, the business earned $2.84 EPS. Waters’s revenue was up 4.0% compared to the same quarter last year. On average, equities analysts anticipate that Waters Co. will post 11.79 EPS for the current fiscal year.

About Waters

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.